Sidley Austin is advising GlycoMimetics, Inc. on the transaction, and Gibson, Dunn & Crutcher is advising Crescent Biopharma, Inc. GlycoMimetics, Inc. (NASDAQ: GLYC) announced it has...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Tower Arch Capital on the transaction, and Jackson Walker advised ACS Manufacturing. Tower Arch Capital announced that it has recapitalized ACS...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher, Willkie Farr & Gallagher and Goldfarb Gross Seligman advised Comply365, LLC on the transaction, DLA Piper and Barnea Jaffa Lande & Co....
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Alcon Inc. on the deal, and Morrison & Foerster advised OcuMension Therapeutics. OcuMension Therapeutics (“OcuMension”), a Hong Kong-listed, China-based ophthalmic pharmaceutical...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Esperion Therapeutics, Inc. on the deal. Esperion Therapeutics, Inc. (Nasdaq: ESPR) announced that it has entered into a Royalty Purchase Agreement...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher is advising J.P. Morgan Growth Equity Partners on the transaction, and Latham & Walkins is advising Tegus. AlphaSense, the leading market intelligence...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher is advising GE Aerospace on the transaction. Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, announced that it has...
You must be a Standard 1 Year member to access this content.
Skadden and Elvinger Hoss Prussen represented Intelsat in the transaction, and Gibson, Dunn & Crutcher and Hogan Lovells represented SES. Debevoise & Plimpton advised Guggenheim Securities...
You must be a Standard 1 Year member to access this content.
Stikeman Elliott LLP and Dorsey and Whitney LLP are acting as legal advisors to Exro; National Bank Financial Inc. is acting as its financial advisor. Gibson,...
You must be a Standard 1 Year member to access this content.
Advisors for Tower Arch Capital included Gibson, Dunn & Crutcher LLP and BDO USA, LLP. Advisors for Midwest included Fabyanske, Westra, Hart & Thomson, PA and...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised XOMA Corporation on the expansion of its commercial royalty and milestone portfolio with the acquisition of an economic interest in...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised 89bio, Inc. on its upsized public offering. 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...
You must be a Standard 1 Year member to access this content.
